Skip to content

Peak plasma propofol levels during endoscopy

Peak plasma propofol levels in endoscopy patients receiving a Propofol-only anaesthetic

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12612000797875
Enrollment
10
Registered
2012-07-30
Start date
2011-09-08
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The peak plasma propofol levels of endoscopy patients (Derived mathematically from the 3 measurements) along with the context sensitive half time of propofol (determined by the length of infusion) will allow the researchers to determine the time taken for plasma propofol levels to drop below levels known to cause driving impairment and thus estimate how long it takes for patients to drive safely after receiving a propofol only anaesthetic.

Interventions

Patients will receive propofol-only anaesthesia using the intermittent bolus technique. Propofol will be administered through an intravenous cannula using the intermittent bolus technique (large loading bolus followed by small frequent boluses) which titrates dosage to adequate sedation. The anaesthetist looking after the patient will give a propofol-only anaesthetic as per his or her usual procedure. The timing and dosage of boluses will not be stipulated by the researchers. The loading dos

Patients will receive propofol-only anaesthesia using the intermittent bolus technique. Propofol will be administered through an intravenous cannula using the intermittent bolus technique (large loading bolus followed by small frequent boluses) which titrates dosage to adequate sedation. The anaesthetist looking after the patient will give a propofol-only anaesthetic as per his or her usual procedure. The timing and dosage of boluses will not be stipulated by the researchers. The loading dose is given immediately prior to commencing the endoscopy. Further boluses are given when deemed required by the anaesthetist.

Sponsors

Monash Medical Centre
Lead SponsorHospital

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Undergoing colonoscopy or gastroscopy

Exclusion criteria

ASA 3 or 4

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026